MIR3179-4

Across TCGA pan-cancer cohorts, MIR3179-4 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR3179-4 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR3179-4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3179-4 expression acts as an unfavorable survival marker.

LUAD, CESC, and SARC are the cancer types where MIR3179-4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.245	0.835	<.001	45	view →
CESC	DFS	Tertile	II,III,IV	0.146	0.705	.010	18	view →
SARC	DFS	Tertile	All	0.101	0.632	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR3179-4–LUAD (OS)

Open the LUAD breakdown →